Table 2.
Demographic and descriptive characteristics of the included studies
| Author | Country | LoE | Patients (N) | Hip (N) | Age (ys) | Sex (M:F) | Stage | Etiology (N) | Technique of CD | Mechanical support | Type and Number of Stem Cells | Follow-up (years) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG | CG | SG | CG | SG | CG | SG | CG | SG | CG | ||||||||
| JOA | |||||||||||||||||
| Yamasaki (2010) | Japan | III | 22 | 8 | 30 | 9 | 41 | 49 | 14:8 | 7:1 |
I:II:III 2:25:3 |
I:II:III 30:8:0 |
SG: corticosteroids (22): Alcohol-abuse (6): Idiopathic (2); CG: corticosteroids (2): Alcohol-abuse (4): Idiopathic (3) |
Single drilling with a 6 ~ 10 mm bur | Interconnected porous calcium hydroxyapatite |
BMMSCs 40 ml 1 × 109 |
2.5 |
| ARCO | |||||||||||||||||
| Gangji (2011) | Belgium | I | 10 | 9 | 13 | 11 | 42.5 | 45.7 | Total: 10:9 |
I:II 2:11 |
I:II 2:9 |
SG: Corticosteroids (11): Alcohol-abuse (1): Idiopathic (1); CG: Corticosteroids (9): Alcohol-abuse (1): Idiopathic (1) |
Drilling with a 3 mm trephine | No mechanical support |
BMAC 50 ml 1.9 × 109 |
5 | |
| Zhao (2012) | China | I | 50 | 50 | 53 | 51 | 32.7 | 33.8 | 27:23 | 26:24 |
I:II 3:50 |
I:II 2:49 |
SG: Corticosteroids (11): Alcohol-abuse (11): Idiopathic (17): Trauma (8): Caisson disease (6); CG: corticosteroids (13): Alcohol-abuse (8): Idiopathic (13): Trauma (12): Caisson disease (5) |
Single drilling with 10 mm trephine | No mechanical support |
BMMSCs 2 ml 2 × 106 |
5 |
| Rastogi (2012) | India | I | 40 | 30 | 30 | 34.7 | 33.0 | 5:2 | 3:1 | I, II, III |
SG: Corticosteroids (10): Alcohol-abuse (2): Idiopathic (14): Other (4); CG: Corticosteroids (8): Alcohol-abuse (6): Idiopathic (12): Other (4) |
Reaming with a 4.5 mm cannulated reamer | No mechanical support |
BMMCs 5 ml 0.1 × 109 |
2 | ||
| Sen (2012) | India | I | 26 | 25 | 26 | 25 | NA | 19:7 | 18:7 | I, II |
Total: Corticosteroids (20): Alcohol-abuse (8): Idiopathic (2): Trauma (17): Pregnancy (2): Cushing disease (2) |
Triple drilling with 4 mm diameter | No mechanical support |
BMAC 2 ml 5 × 108 |
2 | ||
| Liu (2013) | China | III | 17 | 17 | 28 | 27 | 38.0 | 38.1 | 13:4 | 14:3 |
IIb:IIc 13:15 |
IIb:IIc 12:15 |
SG: Corticosteroids (10): Alcohol-abuse (15): Idiopathic (3); CG: Corticosteroids (9): Alcohol-abuse (14): Idiopathic (4) |
Single drilling with a 10 mm outer diameter | Granular porous medical nano-hydroxyapatite / polyamide 66 composite bone filling material |
BMMCs 5 ml 0.16 × 109 |
2.2 |
| Tabatabaee (2015) | Iran | I | 18 | 14 | 14 | 31.0 | 26.8 | 9:5 | 10:4 |
I:II:III 3:9:2 |
I:II:III 2:7:5 |
SG: Corticosteroids (10): Idiopathic (4); CG: Corticosteroids (9): Idiopathic (5) |
Single drilling with 2.7 mm trephine | Allograft bone |
BMAC 58 ml 0.5 × 109 |
2 | |
| Mao (2015) | China | I | 30 | 25 | 48 | 41 | 34.6 | 36.1 | 17:13 | 13:12 |
I:II:III 8:29:11 |
I:II:III 10:23:8 |
SG: corticosteroids (16); alcohol-abuse (18): idiopathic (14); CG: corticosteroids (15): Alcohol-abuse (14): Idiopathic (12) |
Single drilling with 14 mm trephine | Porous tantalum rod |
PBSCs 60 ml 0.25 × 109 |
3 |
| Pilge (2016) | Germany | III | 10 | 10 | 10 | 10 | 38.4 | 38.3 | 9:1 | 8:2 |
II:III:IV 6:3:1 |
II:III:IV 6:3:1 |
SG: Corticosteroids (4): Idiopathic (4): Other (2); CG: Corticosteroids (2): Idiopathic (5): Other (3); |
NA | No mechanical support |
BMAC 7-10 ml |
2.5 |
| Pepke (2016) | Germany | I | 24 | 11 | 14 | 44.3 | 44.5 | 10:1 | 12:2 |
II 11 |
II 14 |
NA | Triple drilling with 2 mm Kirschner wire (K-wire) | No mechanical support |
BMAC 10 ml 1.19 × 109 |
2 | |
| Kang (2018) | Korea | III | 50 | 50 | 53 | 53 | 46.0 | 47.3 | 36:14 | 38:12 |
I:II:III:IV 1:29:19:4 |
I:II:III:IV 1:29:19:4 |
SG: Corticosteroids (5): Alcohol-abuse (19): Idiopathic (24): Other (5); CG: corticosteroids (5): alcohol-abuse (19): idiopathic (24): other (5) |
Multiple drilling with 2 mm K-wires | No mechanical support |
BMMSCs 15 ml 0.2 × 109 |
4.3 |
| Hauzeur (2018) | Belgium | I | 19 | 19 | 23 | 23 | 48.0 | 49.7 | 14:5 | 13:6 |
III 23 |
III 23 |
SG: corticosteroids (12): alcohol-abuse (8): idiopathic (1): drepanocytosis (2); CG: corticosteroids (13): alcohol-abuse (7): idiopathic (3) |
Drilling with a 4 mm trephine | No mechanical support |
BMAC 50 ml 3.46 × 109 |
2 |
| Ficat | |||||||||||||||||
| Lim (2013) | Korea | III | 86 | 21 | 128 | 31 | 36.3 | 34.4 | 69:17 | 16:5 |
IIa:IIb:III 42:37:49 |
IIa:IIb:III 14:9:8 |
SG: corticosteroids (48): alcohol-abuse (20): idiopathic (15): other (3); CG: corticosteroids (6): alcohol-abuse (4): idiopathic (10): other (1) |
Single drilling with 3 mm trephine | No mechanical support |
BMAC 30 ml 8.7 × 108 |
7.3 |
| Ma (2014) | China | I | 21 | 18 | 25 | 24 | 35.6 | 34.8 | 15:6 | 13:5 |
I:II:III 3:17:5 |
I:II:III 4:15:5 |
SG: corticosteroids (13): alcohol-abuse (4): idiopathic (6); CG: corticosteroids (13): alcohol-abuse (3): idiopathic (6) |
Single drilling with 10 mm trephine | Autologous bone graft |
BMAC 1 ml 3 × 109 |
2 |
| Cruz-Pardos (2016) | Spain | III | 45 | 41 | 19 | 42.6 | 36.7 | 27:14 | 14:5 |
I:II 8:33 |
I:II 5:11 |
SG: corticosteroids (14): alcohol-abuse (3): idiopathic (12): other (8); CG: Corticosteroids (6): alcohol-abuse (5): idiopathic (6): other (2) |
Single drilling with 4 mm trephine | No mechanical support |
BMAC 20 ml |
3.8 | |
| Li (2020) | China | I | 17 | 14 | 21 | 20 | 34.1 | 38.2 | 12:5 | 10:4 |
II:III 11:10 |
II:III 11:9 |
SG: corticosteroids (10): alcohol-abuse (6): idiopathic (5); CG: corticosteroids (9): alcohol-abuse (5): idiopathic (6) |
Single drilling with 10 mm trephine | Autologous bone graft |
BMAC 1 ml 3 × 109 |
10 |
| Li (2021) | China | I | 17 | 23 | 22 | 29 | 39.4 | 35.4 | 12:5 | 19:4 |
I:II:III:IV 1:19:2:0 |
I:II:III:IV 1:20:6:2 |
SG: corticosteroids (8): alcohol-abuse (5): idiopathic (9); CG: corticosteroids (3): alcohol-abuse (9): idiopathic (17) |
Single drilling with 10 mm trephine | Autologous bone graft and angioconductive bioceramic rod |
BMAC 3 ml |
2 |
| Steinberg | |||||||||||||||||
| Hernigou (2018) | France | II | 125 | 125 | 125 | 125 | total: 36 | 78:47 | 78:47 |
I:II 69:56 |
Corticosteroids (125) | Single drilling with 4 mm trocard | No mechanical support |
BMAC 90,000 ± 25,000 |
25 | ||
| Total and weighted averages | Asia (12/18), Europe (6/18) | I (11/18), II (1/18), III (6/18) | 916 | 1257 | / | 392:181 | 312:145 | / |
Corticosteroids (45%), alcohol-abuse (21%), Idiopathic (25%), Other (9%) (extracted from the available data) |
Single drilling (14/18), multiple drilling (3/18), NA (1/18) | Mechanical support (7/18), no mechanical support (11/18) | BMAC (12/18), BMMSCs (3/18), BMMCs (2/18), PBSCs(1/18) | 7.5 | ||||
ARCO Association Research Circulation Osseous, BMAC bone marrow aspirate concentrate, BMMCs bone marrow mononuclear cells, BMMSCs bone marrow mesenchymal stem cells, CD core decompression, CG control group, JOA Japanese Orthopaedic Association, LoE level of evidence, PBSCs peripheral blood stem cells, SG stem cell group